USCOM LIMITED — Board/Management Information 2014

Dec 16, 2014

Uscom Limited ABN 35 091 028 090 Suite 1, Level 7, 10 Loftus Street Sydney NSW 2000 Australia T +612 9247 4144 F +612 9247 8157 www.uscom.com.au

M A R K E T A N N O U N C E M E N T

Uscom – Distribution and Sales Manager Appointment

SYDNEY, Australia, 17th December 2014: Uscom Limited (ASX code: UCM) (the Company or Uscom ), a revenue stage, cardiovascular medical devices company, today announced to the market it had appointed Ms Denise Pater to the position of Distribution and Sales Manager.

Ms Pater has nearly 20years experience in medical device distribution, sales, marketing, business development and management, having previously been employed by GE Healthcare, Datex-Omeda, Medtel and Ramsay Healthcare. Ms Pater came to medical device management with a critical care clinical nursing background.

Ms Pater’s role will be to co-ordinate and target current resources within the company to support and motivate the growing worldwide Uscom distribution network, and to develop specific new business initiatives. Denise will be responsible for management of the distribution and sales efforts for both the USCOM 1A and the Uscom BP+ technologies globally.

Ms Pater said “Uscom has a growing global reputation as an outstanding and innovative medical technology company with great cardiovascular products, and joining the Company now, as it enters a rapid growth phase, is very exciting. I intend to improve the effectiveness of our growing distribution channels so we can optimise the sales opportunities and enlist new and larger distributors. I’m anticipating healthy revenue growth off the back of improved current distribution, and new appointments and marketing activities. I’m particularly optimistic about the potential for the newly developed Uscom BP+ central blood pressure monitor in hypertension trials with global pharmaceutical companies. Uscom BP+ is a real solution for them as they seek to improve their research methods and reduce the cost of their trials.”

Executive Chairman of Uscom, Dr Rob Phillips said “ Denise is an experienced and respected member in the medical technology world and her contribution to Uscom management will be vital as we accelerate into our growth phase. Denise is an important next step in our expansion, and her skills in distributor management, marketing and sales compliment our already strong team. Her objective is to focus and co-ordinate Uscom resources to drive our global distribution partners and achieve significant sales and revenue growth.”

Uscom manufactures and markets the USCOM 1A and the Uscom BP+, both premium cardiovascular devices changing the way cardiovascular diseases are diagnosed and treated. The devices have specific application in hypertension, heart failure and sepsis, and improve the use of fluid, inotropes and vasoactive therapies.

Uscom Limited

ABN 35 091 028 090 Suite 1, Level 7, 10 Loftus Street Sydney NSW 2000 Australia T +612 9247 4144 F +612 9247 8157 www.uscom.com.au

M A R K E T A N N O U N C E M E N T

About Uscom

Uscom Limited (UCM) is an ASX listed cardiovascular medical device company. Uscom is an innovative developer and manufacturer of premium cardiovascular devices and has two practice leading technologies in the field of cardiovascular monitoring, the USCOM 1A and the Uscom BP+. Both devices are clinically validated with FDA, CE and TGA regulatory approval, and are currently being marketed into global distribution networks.

The USCOM 1A is a simple, cost-effective and non-invasive device that measures heart function, detects abnormalities and guides treatment. The USCOM 1A device has major applications in Paediatrics, Emergency, Intensive Care Medicine and Anaesthesia, and is the device of choice for management of adult and paediatric sepsis, heart failure, and for the guidance of fluid therapy.

The Uscom BP+ is a supra systolic Central Blood Pressure monitor and replaces older and more widespread BP sub systolic Blood Pressure monitoring technology. Central Blood Pressure is becoming the new standard of care measurement in hypertension and heart failure. The Uscom BP+ provides a highly accurate and repeatable measurement of central and brachial blood pressure and pulse pressure waveforms using a familiar upper arm cuff. The BP+ is simple to use and requires no complex training with applications in cardiology, intensive care, general practice and home care.

For more information, please visit: www.uscom.com.au

Uscom Contacts

Rob Phillips Executive Chairman rob@uscom.com.au Ph: +61 2 9247 4144

Catherine Officer Company Secretary secretary@uscom.com.au